Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial

Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial

Afficher d'autres versions (1)

<p><strong>Background</p></strong> Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a proinflammatory cytokine overproduced in several inflammatory and autoimmune diseases, including axial spondyloarthritis. Namilumab is a human IgG1 monoclonal anti-GM-CSF antibod...

Description complète

Détails bibliographiques
Auteurs principaux:	Worth, C, Al-Mossawi, MH, MacDonald, J, Fisher, BA, Chan, A, Sengupta, R, Packham, J, Gaffney, K, Gullick, N, Cook, JA, Corn, TH, Teh, J, Machado, PM, Taylor, PC, Bowness, P
Format:	Journal article
Langue:	English
Publié:	Elsevier 2024

Documents similaires

A first in disease phase 2A trial of granulocyte monocyte colony stimulating factor neutralisation for axial spondyloarthritis (NAMASTE study)
par: Al-Mossawi, MH, et autres
Publié: (2021)

Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial
par: Worth, C, et autres
Publié: (2024)

Novel therapeutic targets in axial spondyloarthritis
par: Worth, C, et autres
Publié: (2018)

„CORONA VIRUS HANDLING – ‘NAMASTE’“
par: Sande Smiljanov
Publié: (2022-06-01)

Elevated type-17 cytokines are present in Axial Spondyloarthritis stool
par: Brough, I, et autres
Publié: (2024)

STRATEGI PROMOSI EVENT NAMASTE FESTIVAL
par: Arie Wibowo
Publié: (2015-11-01)

Rheumatological manifestation of diabetes: “Namaste” sign
par: M Mahesh, et autres
Publié: (2018-01-01)

BROMODOMAIN INHIBITORS REDUCE TH17-TYPE RESPONSES IN SPONDYLOARTHRITIS IN VITRO
par: Hammitzsch, A, et autres
Publié: (2014)

The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis
par: Al-Mossawi, M, et autres
Publié: (2013)

The role of natural killer cells, gamma delta T-cells and other innate immune cells in spondyloarthritis.
par: Al-Mossawi, M, et autres
Publié: (2013)

«FLARES» IN AXIAL SPONDYLOARTHRITIS
par: Sh. F. Erdes
Publié: (2016-07-01)

Progression of axial spondyloarthritis
par: Sh. F. Erdes, et autres
Publié: (2021-06-01)

Etanercept in axial spondyloarthritis
par: Gui Luo, et autres
Publié: (2022-11-01)

Pathogenic immune responses in Spondyloarthritis
par: Al-Mossawi, M
Publié: (2016)

Assessing fatigue in adults with axial spondyloarthritis: a systematic review of the quality and acceptability of patient-reported outcome measures
par: Pearson, N, et autres
Publié: (2018)

Qualitative interview study exploring the patient experience of living with axial spondyloarthritis and fatigue: difficult, demanding and draining
par: Pearson, N, et autres
Publié: (2022)

Coxitis in early axial spondyloarthritis
par: E. M. Agafonova, et autres
Publié: (2019-10-01)

Oxford textbook of axial spondyloarthritis
par: Vinod Ravindran
Publié: (2017-01-01)

Ankylosing spondylitis-axial spondyloarthritis
par: Aanand Narayan Malaviya
Publié: (2017-01-01)

Axial Spondyloarthritis: An Evolving Concept
par: Nelly Ziadé
Publié: (2015-07-01)

Namaste (counterbalancing) technique: Overcoming warping in costal cartilage
par: Kapil S. Agrawal, et autres
Publié: (2015-05-01)

Management of Axial Spondyloarthritis – Insights into Upadacitinib
par: Braun J, et autres
Publié: (2022-10-01)

Development of the Warwick axial spondyloarthritis fatigue and energy questionnaire (WASTEd)—a new patient-reported outcome measure
par: Pearson, NA, et autres
Publié: (2022)

Qualitative interview study exploring the patient experience of living with axial spondyloarthritis and fatigue: difficult, demanding and draining
par: Kirstie Haywood, et autres
Publié: (2022-02-01)

Namaste position-an option for patient position in pediatric anorectal surgeries
par: Debasish Mitra, et autres
Publié: (2013-01-01)

HLA-B27 and KIR3DL2 Interactions Promote The Differentiation and Survival Of Proinflammatory T Cells In Spondyloarthritis
par: Ridley, A, et autres
Publié: (2013)

CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS
par: Sh. F. Erdes
Publié: (2016-02-01)

Etanercept in axial spondyloarthritis – treatment efficacy
par: I. Z. Gaydukova, et autres
Publié: (2022-03-01)

Editorial: Radiographic progression in axial spondyloarthritis
par: F. M. Pimentel-Santos, et autres
Publié: (2023-06-01)

Targeting inflammatory pathways in axial spondyloarthritis
par: Daniel E. Furst, et autres
Publié: (2019-06-01)

The Role of Imaging in Diagnosing Axial Spondyloarthritis
par: Nikita Khmelinskii, et autres
Publié: (2018-04-01)

Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates
par: Simone, D, et autres
Publié: (2021)

Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates
par: Simone, D, et autres
Publié: (2021)

Classification Terminology and Definitions in Reporting of MRI in Axial Spondyloarthritis
par: Danishta Ramdin, et autres
Publié: (2017-12-01)

Spectrum of spondyloarthritis
par: Himanshu Pathak, et autres
Publié: (2020-01-01)

Comparative characteristics of axial spondyloarthritis and psoriatic arthritis with axial involvement
par: Е. Е. Gubar, et autres
Publié: (2024-04-01)

Factors Associated with Poor Mental Health in Patients with Axial Spondyloarthritis: Results from the International Map of Axial Spondyloarthritis (IMAS)
par: Denis Poddubnyy, et autres
Publié: (2024-05-01)

An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis
par: Paccou J, et autres
Publié: (2016-07-01)

Initiatives: National Ayush Morbidity and Standardized Terminologies Electronic (NAMASTE) Portal
par: Saketh Ram Thrigulla, et autres
Publié: (2023-07-01)

Serum granulocyte-macrophage colony-stimulating factor (GM-CSF) is increased in patients with active radiographic axial spondyloarthritis and persists despite anti-TNF treatment
par: Charalampos Papagoras, et autres
Publié: (2022-08-01)